Search Results Page

Divis Labs firmly in the red

about 10 years ago

Divis Labs is literally butchered to pulp since Friday. Today it hit a 28-month low at Rs.745, down 14% and since Friday, this is a collective drop of 33%. The reason is the report put out by broking firm, Emkay Global. The report was pretty scathing saying that the company had received an o ...

Divis Labs in the limelight

about 10 years ago

Divis Laboratories is in the limelight today, following the company’s very good Q1FY17 performance. The stock price hit an intra day high of Rs.1237.60, close to its 52-week high of Rs.1241.80. Volumes are up almost two times. The company posted a good 23% (YoY) rise in net profit at R ...

Divi’s Labs hits a new high

about 8 years ago

Divi’s Labs rose over 14% to Rs.1433.35, hitting a new 52-week high today as its Q2FY19 net profit almost doubled, following which fund houses and brokerages have upgraded the stock.

Alkem Labs 'observed' in the red

about 10 years ago

Alkem Labs had been hitting new highs consistently this almost entire week. In fact yesterday too, it hit a new high at Rs.1852.95. Though today the counter is streaked in red. Intra day the stock slipped over 8% to Rs.1655 and has since then recovered to Rs.1700, nevertheless, down 6%. Yest ...

IPCA Labs tanks into deep red

about 9 years ago

IPCA Labs is the top loser on the BSE, going down almost 15.5% to Rs.437, which is very close to its one-year low of Rs.435. Volumes are massive – from a two-week average of 5072 shares being traded, today morning alone over 5 lakh shares were traded.

Vivimed Labs in the limelight

about 9 years ago

Vivimed Labs is in the limelight today morning. The stock which had closed yesterday at Rs.105.05, rose to an intra day high at Rs.113.90, going up 8%. Volumes are all good.

Divi's Labs up in the green

about 10 years ago

On Saturday, Divi’s Labs stated that the US FDA exempted some more products from the import alert. These products are manufactured at its Unit –II, Visakhapatnam facility.

Divi’s Labs

about 10 years ago

Divi’s Labs is the top loser on the BSE currently; down almost 19% at Rs.642.25 and this is after hitting a new 52-week low at Rs.635.

Vivimed Labs in the limelight

about 10 years ago

Vivimed Labs is most certainly the “star” on the bourses today. The counter is showing some tremendous amount of volumes and the stock price has spurted up 10% to over Rs.101. Its 52-week high stands at Rs.121.15. The reason for this joy on the counter is twofold – firstly, ...

Morepen Labs on the rise

about 10 years ago

Morepen Labs is currently at its intra day high point at Rs.29.95, up 12% though closer to its 52-week low of Rs.13.40 than the high of Rs.41.80. This maker of Burnol, has surged on unconfirmed news that the company may sell its OTC (over-the-counter) business of market leading brands such a ...

Divi's Labs slumps on poor Q1

about 9 years ago

Divi’s Labs is the second top loser on the BSE, going down over 5.5% to Rs.680.35. Its 52-week high is at Rs.1380 and low at Rs.533.10.

Ipca Labs hits a new 52-week low

about 11 years ago

IPCA Labs is the top loser on the BSE currently, hitting a new 52-week low at Rs.480. The reason for this selling on the counter is the latest update from the company. It has informed that Global Fund of Switzerland has informed the Company that in the light of the warning letter issue ...

Divi's Labs in the limelight

about 11 years ago

Divi’s Labs is in the limelight today. The stock which had closed on Friday at Rs.993.90, opened today at Rs.1022.90, its intra day high point. The good news on the counter is that the company had a successful inspection by the US-FDA for its Unit-2 at Chippada, Bheemunipatnam near Vis ...

Unichem Labs zooms on bumper Q3

about 11 years ago

Unichem Labs posted a bumper set of numbers for Q3FY16. Its net profit soared almost 10 times to Rs.20 crore and this was on the back of super topline. Its net sales for the quarter was up 15% (YoY) at Rs.306 crore. Revenue from domestic formulations rose 19% while that from international fo ...

Vivimed Labs in good health

about 11 years ago

Vivimed Labs is up in the green today morning. The stock opened Rs.11 higher at Rs.336 and went on to an intra day high at Rs.347. It has since then come off the high and is now at Rs.339, up 3.5%. The stock is up on news that the company has entered into an agreement with Clariant to sell i ...

Jyothi Labs brings Ujala in dark market

about 11 years ago

The 52-week high of Jyothi Labs stands at Rs,342 and today it inched so close to it at Rs.334. Currently up 5% at Rs.322, the counter has clocked, mid-morning, trades of 79,000 shares compared to two-week average of 16,000 shares. This spike up in interest on the counter is thanks to unconfi ...

Divi's Labs at new high

about 11 years ago

Divis Labs is one of the big stars on the market today. It has hit a new high at Rs.2129, which is a good 8% jump over previous close. Volumes are robust at over four times. This Hyderabad company engaged in the manufacture of API posted a very good performance for Q1FY16. On a 26% (YoY) ris ...

IPCA Labs under FDA radar

about 12 years ago

IPCA Labs is down in the dumps today. The stock has slumped 11.5% or by over Rs.87 at Rs.672.85 with an intra day low at Rs.665.25. Volumes are huge at almost 5.5 lakh compared to 2-week average of 1.30 lakh shares. The US FDA bug has afflicted this company too. The company has informed that ...

Alkem Labs buzzes and fizzles

about 9 years ago

Alkem Labs was buzzing loud and strong in the morning trades. The stock price surged over 3% on opening to Rs.1844 – its intra day high point and after that it fizzled – it continues to remain in the green but just about.

Dr.Reddy’s Labs tastes bitter

about 9 years ago

Dr.Reddy’s Labs is down in the red since morning, going down over 6% to Rs.2462 levels and remains now also around same levels.

Ranbaxy Labs bounces back to new high

about 12 years ago

Ranbaxy Labs is doing very well. The stock has hit a new high today at Rs.657.65 and currently hovers around the same levels. The stock was dumped on Friday due to a penalty of Rs.240 crore allegedly levied on the company by the state of Texas. But today, the same stock has hit a new high on ...

Dr.Reddy’s Labs turns jittery

about 8 years ago

Dr.Reddy’s Labs is down in the red today morning. Figuring among the top three losers on the BSE, the stock price slumped 9% to Rs.2115 levels, with intra day low currently at Rs.2110.

Diagnostic labs test positive!

about 7 years ago

Diagnostic labs, listed on the bourses are doing extremely well today. Thyrocare Technologies and Lal Path Labs are among the top gainers since the opening bell.

Neuland Labs jumps over 11%

about 7 years ago

This news led to an over 11% spike up in the stock price of Neuland Labs to Rs.480.30 with volumes jumping up almost 13 times. Its 20% UC for today is at Rs.517.95.

Morepen Labs torpedoed by SEBI

about 7 years ago

Morepen Labs is in the news today and not in a good way. The stock has lost almost 17.5% in the morning trades, to hit an intra day low at Rs.18, which is not too far from its 20% L

Unichem Labs jumps over 5%

about 7 years ago

Unichem Labs is in the limelight today morning. The stock opened at Rs.171.10, rising over 2.2% and went on to an intraday high at Rs.178.65, a jump of over 5%.

Laurus Labs jumps almost 3.5%

about 7 years ago

Following this news, Laurus Labs rose almost 3.5% to Rs.337, with volumes showing a jump of 2 times.

Unichem Labs rises almost 5%

about 8 years ago

Unichem Labs has outperformed the sector today by 2.15%. Stock has been gaining for the last 3 days and has risen 5.20% in the period

Dr.Reddy’s Labs in deep red

about 8 years ago

Dr.Reddy’s Labs is in serious deep red today morning, with the stock price falling 8% to Rs.2555.55. Its 52-week high and low stands at Rs.2875 and Rs.1888 respectively.

Dr.Reddy’s Labs turns jittery

about 8 years ago

Though it has recovered now, Dr.Reddy’s Labs was a big loser in the opening bell session. The stock lost over 2.5% at Rs.2290 and since then, it has recovered to Rs.2332.60.

Laurus Labs in good health

about 9 years ago

Laurus Labs is doing very well today. The stock price rose 3.5% to Rs.555 and it remains firmly in the green in this morning session.

Laurus Labs in the red

about 9 years ago

Laurus Labs has slipped into the red today, going down 5.5% to Rs.510.45 and is the top loser on the BSE currently. The stock’s 52-week low is at Rs.468.

Dr.Reddy’s Labs in the red

about 9 years ago

Dr.Reddy’s Labs is down in the red today morning, declining over 4.5% to Rs.2299. Its 52-week high and low is at Rs.3203.95 and Rs.1901.65 respectively.

Laurus Labs jumps up 5%

about 9 years ago

Laurus Labs rose 5% to an intra day high today morning at Rs.550. Its 52-week high and low stands at Rs.634 and Rs.453 respectively.

Dr.Reddy’s Labs in good health

about 9 years ago

Dr.Reddy’s Labs rose over 9.5% to an intra day high at Rs.2498 and continues to remain firmly in the green. Its 52-week high and low is at Rs.3247 and Rs.1901.65 respectively.

Dr.Reddy’s Labs among top gainers

about 9 years ago

Dr.Reddy’s Labs is among the top five gainers on the BSE; the stock price soared over 6.5% to Rs.2466.40 and continues to remain firmly in the green

Divi's Labs improves health

about 9 years ago

Divi’s Labs today rose 6.5% to Rs.919.50 and continues to remain firmly in the green. Its 52-week high and low stands at Rs.1355.45 and Rs.533.10 respectively.

Alkem Labs slips into red

about 9 years ago

Today morning, Alkem Labs stated that the US FDA had conducted an inspection at the Company's manufacturing facility located at Baddi, India from 11th September, 2017 to 15th September, 2017.

Ranbaxy Labs gets another bitter pill

about 12 years ago

Ranbaxy Labs cup of woes continues to overflow. The ongoing trouble with US FDA apart, there is now another ruling from the US Court, which disallowed the company’s plea to block its competitors from launching the generic versions of Nexium and Valcyte in USA. Ranbaxy was the first genric f ...

Divi’s Labs surges over 21%

about 9 years ago

Divi’s Labs has surged over 21% to Rs.1117 today morning and remains the top gainer on the BSE. Volumes are robust, up over 7 times.

Ranbaxy Labs top loser

about 14 years ago

Ranbaxy Labs is currently the top loser on the BSE, down over 7% at Rs.402.35, with an intra day low at Rs.401. Its 52-week low stands at Rs.370.50. The stock is down the red after Daiichi, the Japanese owners of the company today, plan to sue the former promoters of the company – Malv ...

Unichem Labs in poor health

about 12 years ago

Unichem Labs is down almost 4% at Rs.188.55, closer to its intra day low of Rs.187. The 52-weeklow stands at Rs.138. The stock is in the red, post the dismal numbers it posted for Q1FY15. The company, for Q1, posted a 16% (YoY) drop in net profit at Rs.30 crore. This was on the back of lower ...

IPCA Labs spooked by US FDA

about 12 years ago

IPCA Labs is currently the top loser on the BSE, down 9% at Rs.763.60, with an intra day low at Rs.752 and this was though the stock had opened at Rs.832. The stock reacted sharply to the announcement made by the company in the early trading hours that it had voluntarily stopped shipments fr ...

Divi's Labs hits new high

about 13 years ago

Divi’s Labs is on the go today. The stock opened higher at Rs.1365, went on to hit a new 52-week high at Rs.1390 and it is currently at Rs.1381.40, up over 5%. Volumes are up over one times. The stock is riding high on the back of its very good Q3FY14 numbers. Beating all estimates, th ...

IPCA Labs on the buzz

about 13 years ago

IPCA Labs last month had hit a new 52-week high at Rs.744.35 and today the stock is once again showing activity. The stock had closed yesterday at Rs.686 and it opened today at Rs.689.90 and went on to hit an intra day high at Rs.696. The stock is buzzing on news which it announced yesterday ...

Ranbaxy Labs top loser

about 13 years ago

Ranbaxy Labs is the top loser on the BSE currently, down by a whopping 24% or by Rs.110 at Rs.346.50. The stock had hit an intra day low at Rs.297.25. Its 52-week low is at Rs.253.95. The stock has slipped deep into the red today morning as once again the US FDA issue has come haunting back. ...

Ranbaxy Labs behaves contrary

about 13 years ago

Ranbaxy Labs is behaving in the most Quixotic manner. The stock posted a huge loss on the back of forex losses and yet currently, it is the top gainer on the BSE. The stock is up almost 13% at Rs.318.25, with an intra day high at Rs.320.40. Volumes are huge at almost 8 lakh shares compared to 2.3 ...

Divi's Labs down after poor numbers

about 14 years ago

Divi’s Labs is currently the top loser on the BSE, down almost 7% at Rs.1015, with an intra day low at Rs.1011. The stock is witnessing selling after it declared its Q4FY13 wherein it posted a set of disappointing numbers. Its consolidated net profit slumped 17% (YoY) at Rs.180 crore o ...

Laurus Labs rises 5%

about 6 years ago

Following this news, the stock price rose 5% to Rs.298.80 and has come off this level and is currently trading at Rs.292. Its 20% UC for the day is at Rs.342.05

Divi's Labs in serious trouble?

about 9 years ago

There is a very damaging report from Bloomberg which took the effort of accessing the Form 483 and scrutinizing the report. What it has come up with is shocking – it has stated that contrary to the company

Divi’s Labs slumps

about 5 years ago

The stock price opened 2.5% lower at Rs.5082.35 and went down to hit an intraday low at Rs.4751. Its 10% LC for the day is at Rs.4684.55.

Laurus Labs

about 10 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Divi’s Labs in the red

about 5 years ago

The stock had hit a new high yesterday at Rs.5313.80 though it ended at Rs.5220.50. Today, it opened higher at Rs.5260 and profit booking

Unichem Labs surges

about 6 years ago

It rose almost 5% to hit an intraday high at Rs.267.65, on the back of robust volumes . Its 52-week high stands at Rs.304.20.

Unichem Labs shines bright

about 7 years ago

It opened over 7% higher at Rs.136.70 and rose to an intraday high at Rs.139.70, which is very close to its 10% UC of the day at Rs.140.15.

Ipca Labs slumps post Q2

about 6 years ago

The stock, which had closed at Rs.2336.80 on Friday, opened over 1% lower at Rs.2310 and slipped further by over 3%

Divi’s Labs at new high

about 6 years ago

The market is obviously super thrilled with the numbers as it went on to hit a new high today at Rs.3448.10 and continues to figure among the top five gainers

Unichem Labs smart gainer

about 5 years ago

The stock is among the top five gainers on the BSE since morning, opening over 3.5% up at Rs.231.40, rising over 15% to hit an intraday high at Rs.257.

Dr.Reddy’s Labs at new high

about 6 years ago

The stock did not react as much yesterday on news of Russia’s vaccine for Covid. But today, it went on to hit a new record high at Rs.5302.85

Divi’s Labs in the limelight

about 7 years ago

The stock price has reacted positively to this news and it rose 2.3% to Rs.1561.75, it has come off this intraday high and is now at Rs.1551 levels.

Divi’s Labs down 6.5%

about 6 years ago

The stock opened in the red today, down over 5.5% and going down 6.5% to hit an intraday low at Rs.2094.60. It has recouped from this low

Lyka Labs new high again

about 5 years ago

Today, the stock, which had closed yesterday at Rs.129.15, opened itself at its 5% UC of the day at Rs.135.60, a new high again. On the other hand, Ipca went down 2%

Amagi Media Labs

about 9 months ago

Not Worth Consuming
Subscription Start Date :13 Jan 2026 End Date :16 Jan 2026
Issue Size : Rs. 1,789 cr, Issue Type : Fresh cum OFS
Price Band : Rs.343 to Rs. 361
--------------------------------------------------
Overall Subscription : 30.22x
QIB : 33.77x,HNI :37.36x,Retail :9.31x
Listing Date : 21 Jan 2026, , Listing Price : 318

Lyka Labs at 5% UC

about 5 years ago

The stock which had closed yesterday at Rs.219.95, opened at Rs.229 and within seconds hit the 5% UC of the day at Rs.230.90 where it now remains frozen.

Pine Labs

about 11 months ago

Nothing’s Fine
Subscription Start Date :7 Nov 2025 End Date :11 Nov 2025
Issue Size : Rs. 3,900 cr, Issue Type : Fresh cum OFS
Price Band : Rs.210 to Rs. 221
--------------------------------------------------
Overall Subscription : 2.46x
QIB : 4x,HNI :0.3x,Retail :1.22x,Other :7.35x
Listing Date : 14 Nov 2025, , Listing Price : 242

Pine Labs lists tall

about 11 months ago

As against the IPO price of Rs.221, the stock for listed on the BSE at Rs.242 and rose to an intraday high at Rs.283.70 and is now trading at Rs.260 levels.

Alkem Labs down 3%

about 3 years ago

The stock is figuring among the top losers on the BSE since the opening bell today; opening 2% lower at Rs.4889.60, the stock further slumped down to Rs.4849.30, down 3%.

Laurus Labs down 10%

about 3 years ago

The stock is currently the top loser on the BSE; from its close of Rs.398.55, the stock today opened much lower at Rs.358.70, its current intraday low, down 10%. Its presently trading at Rs.370 levels, down 7%.

Jyothy Labs at new high

about 3 years ago

The stock, which had closed yesterday at Rs.242.25, went on to hit a new 52-week high today at Rs.289.15 and remains strongly in the green.

Laurus Labs lists at 15% premium

about 10 years ago

Drug maker, Laurus Labs, which had set the IPO price on the upper price band at Rs.428, opened with a huge gap at Rs.490, up almost 15% over IPO price. But it has not been able to sustain at this level and is now down to Rs.475, nevertheless up 11% over IPO price. The issue was subscribed ov ...

Divi’s Labs up and about

about 3 years ago

Though the stock opened around 0.25% lower at Rs.3090 and slipped further to Rs.3050, it bounced back sharply from these levels to Rs.3197.35, up over 3%

Morepen Labs rises 17%

about 4 years ago

The stock is currently the top gainer on the BSE; the stock price rose almost 17% to hit an intraday high at Rs.27.80, not too far from its 20% UC of the day at Rs.29.31.

Divi’s Labs gets bitter

about 4 years ago

The stock is among the top five gainers on the BSE today, falling over 9% to hit an intraday low at Rs.3407.40 and remains in the red.

Unichem Labs in good health

about 9 years ago

Based on this news, the stock price of the company rose to an intra day high at Rs.277, up over 6.5%. Its 52-week high and low stands at Rs.319.90 and Rs.239.05 respectively.

Laurus Labs buzzing loud

about 5 years ago

Though it opened flat at Rs.539.90, it soon zoomed up to an intraday high at Rs.568; its 10% UC of the day stands at Rs.593.15.

Purple Style Labs

about 2 months ago

Very Pricey
Subscription Start Date :31 Aug 2026 End Date :2 Sep 2026
Issue Size : Rs. 680 cr, Issue Type : Fresh Issue
Price Band : Rs.546 to Rs. 575
--------------------------------------------------
Overall Subscription : 1.29x
QIB : 1.43x,HNI :0.84x,Retail :1.58x
Listing Date : 7 Sep 2026, , Listing Price : 539

Alkem Labs rises almost 4.5%

about 7 years ago

The stock opened today with a gain of over 2% at Rs.2377.35 and went on to hit an intraday high at Rs.2424.10,

Ipca Labs at new high

about 7 years ago

In the market carnage, this is one stock which has hit a 52-week high at Rs.1615.17, a jump of over 17%.

Neuland Labs at new high

about 6 years ago

The stock, which had closed yesterday at Rs1390.65, opened higher at Rs1456 and went on to hit a new high at Rs.1534.10.

Zim Labs hits new high

about 5 years ago

The stock opened 3.5% higher at Rs.120 and went on to hit a new high at Rs.139. It is currently trading at Rs.137 levels.

Zenotech Labs hits 5% UC

about 5 years ago

The stock which had closed yesterday at Rs.50.50, opened itself today at Rs.53, hitting its 5% UC of the day. Almost 2 lakh pending buy orders remain

Vivimed Labs at 5% UC

about 6 years ago

The stock, which had closed yesterday at Rs.16.75, opened lower at Rs.16.35 and from there, it shot up to straight hit the 5% UC

Divi’s Labs at new high

about 6 years ago

The stock, which had closed on Friday at Rs.2784.25, opened much higher at Rs.3062 and went on to hit an all-time high at Rs.3228.05

IPCA Labs spooked by US FDA

about 12 years ago

Once again, Bhushan Steel retains the unenviable position as numero uno loser on BSE while the second best loser today is IPCA Labs. The stock, which had closed yesterday at Rs.724.85, opened lower at Rs.676 and tanked to an intra day low at Rs.650. Its 52-week low is at Rs.609. It currently rema ...

Jyothy Labs spreads 'Ujala'

about 13 years ago

Jyothi Laboratories announced its Q3FY14 numbers yesterday afternoon and the stock has reacted strongly today, up 4.5% at Rs.201.75, close to its intra day high at Rs.202. Volumes are up over 1 time. The stock is riding high on the back of its exuberant Q3FY14 numbers. The company which make ...

Morepan Labs hits a new high

about 9 years ago

Morepan Laboratories hit a new high today at Rs.29.40 and remains some 16% higher over yesterday’s close of Rs.25.25. Volumes are also pretty robust over 2.5 times.

Zenotech Labs hits the roof again

about 13 years ago

Zenotech Laboratories has been breaching the upper circuit for a couple of days now and today too, it hit the 5% upper circuit at Rs.23.30, with an over one time rise in volumes. The stock has been hitting the roof consistently as news was expected to come from Sun Pharma on the open offer a ...

Alkem Labs drops 9%

about 11 years ago

Alkem Labs, intra day dropped 7% to Rs.1271. It has since then recovered but remains in the red, down 4% at Rs.1313. The stock is down after the company announced that the UK Medicines and Healthcare Products Regulatory Agency has made eight observations on the company's bioequivalence f ...

Alkem Labs

about 11 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Brooks Labs

about 15 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Jyothy Labs

about 19 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Dr.Reddy’s Labs among top gainers

about 9 years ago

Dr.Reddy’s is among the top gainers on the BSE currently. The stock price rose over 6% to Rs.2328 and continues to remain firmly in the green.

IPCA Labs in limelight

about 13 years ago

IPCA Laboratories is doing pretty well today morning, currently up 2% at Rs.802.90, with an intra day high at Rs.803.90. The stock is grabbing some attention today after it announced that the company has entered into an agreement with US based company, Oncobiologics Inc for the development a ...

Dr.Reddy’s gets some reprieve

about 9 years ago

Dr.Reddy’s Labs had a lot of reason to cheer today on Dalal Street. The stock rose over 2% to Rs.2681 and continues to remain in the green. Volumes remain calm showing there is interest but not a clamor to get the shares.

Dr.Reddy's spooked by US FDA

about 11 years ago

Not surprisingly, Dr.Reddy’s Labs is the top loser on the BSE currently. Intra day the stock was down almost 14% at Rs.3664.05 and even now, it is down almost 13.5% at Rs.3686 levels. Volumes have surged almost 5 times. The stock is down, reacting to its announcement which came in toda ...

Pharma stocks in reckoning

about 4 months ago

The rally was broad-based, with Dr. Reddy’s gaining up to 2.6%, Cipla nearly 3%, Laurus Labs over 3%, Zydus Lifesciences around 2.8%, Sun Pharma over 1.5%, while Piramal Pharma surged more than 8% on the supply-opportunity trigger.

Ranbaxy slumps deep into red

about 13 years ago

Ranbaxy Labs is currently the top loser on the BSE, down over 15% at Rs.353.30, with volumes spiking up almost 3 times. The stock went as low as Rs.335 or almost 20% in the early morning trades. The stock is down on news coming in that US FDA has banned imports to USA from Ranbaxy due to man ...

"Labs" on a new high

about 6 years ago

Thyrocare Technologies hit a new high today at Rs.1038.60, surging up 17.5% and so did Lalpath Labs and Metropolis.

Ranbaxy and Sun in limelight

about 13 years ago

The big news today is most obviously the takeover of Ranbaxy Labs by Sun Pharma. The announcement came in today morning and the stocks have reacted accordingly – with Ranbaxy hitting a new 52-week high at Rs. 505 but now it has slipped into the red, down 3% at Rs.446; Sun is currently tradi ...

Caplin Point continues to rise

about 12 years ago

Caplin Point Labs did very well yesterday and today too, it continues to do well. Yesterday, it had breached the upper circuit at Rs.264.25 and today, it opened higher at Rs.266 levels and is currently at Rs.273, up 4.6%. The stock is up after the company yesterday announced that its plant a ...

Ranbaxy's pill gets bitter

about 12 years ago

Ranbaxy Labs is back in the limelight and once again, not in good light. The stock has been hitting new highs since 18th Aug and yesterday, it had hit a new high at Rs.648.55 and today it has slipped down to Rs.626.60. Currently it remains in the red. The stock has been dumped once again tod ...

Dr.Reddy's slumps on Russian worries

about 12 years ago

Dr.Reddy’s Labs was a prominent loser on the bourses yesterday and today too, it continues with the falling trend. The stock price is down currently almost 2% at Rs.3085 after opening at Rs.3117. It hit an intra day at Rs.3060. The market is nervous about the impact of the falling roub ...

Dr.Reddy’s gets a bitter taste

about 8 years ago

Over the last three sessions, Dr.Reddy’s Labs has losing and has fallen 9% during this time; today it is the top loser since morning, going down 7.5%

Dr.Reddy’s down in the red

about 10 years ago

Dr.Reddy’s Labs posted a dismal set of numbers for Q3FY17. Its net profit for the quarter slipped 19% (YoY) at Rs.470 crore on a 7% drop in total revenues at Rs.3706 crore.

Dr.Reddy’s gets going

about 8 years ago

Dr.Reddy’s Labs rose over 4% to Rs.2553 and though it has come off this intra day high, it remains firmly in the green.

Dr.Reddy's in the red

about 8 years ago

Dr.Reddys Labs had a bad start to the week today. The stock fell almost 2.5% to Rs.2280 and continues to remain in the red.

Dr.Reddy's spooked by Lundin

about 11 years ago

Dr.Reddy’s Labs is amongst the top losers of the day currently. The stock is down almost 3% at Rs.3280, with an intra day low at Rs.3140. Its 52-week low is at Rs.3010. The stock is down on unconfirmed reports that the company is caught in a probe – Lundin Law PC has announc ...

Ranbaxy once again top loser

about 13 years ago

Ranbaxy Labs is the big loser on the BSE currently, down 5% at Rs.333, with an intra day low at Rs.302. The stock had hit a 52-week low on 2nd Aug at Rs.253.95. The stock is once again down as issues from US FDA continue. Fresh trouble is brewing for the company after the company stated that ...

Caplin Point locked at 10% UC, again

about 8 years ago

Caplin Point Labs is once again, third day in a row, locked at the 10% UC today morning at Rs448.

Dr.Reddy’s tanks over 7%

about 9 years ago

Dr.Reddy’s Labs is the top loser on the BSE, falling over 7% to Rs.2066.15.

JHS Svendgaard on UC

about 11 years ago

JHS Svendgaard Labs has been hitting the upper circuit since 1st of March and today too it breached the 5% UC at Rs.23.40 with volumes going up over one time. The stock is reacting positively to the news that its Board approved conversion of 1.02 crore warrants into equity shares. As per ...

Debutants make a grand entry

about 11 years ago

Two new stocks got listed on the bourses today. Dr,Lal Path Labs and Alkem Labs and both had a spectacular opening. Dr.Lal Path Labs which fixed its price at the upper range at Rs.550 got listed at Rs.717, a whopping 30% jump over issue price. Alkem Labs too did very well. It ...

INVESTING - BEING LIKE 'THE DISCIPLE'?

about 6 years ago

On the Indian bourses, the pathological labs are scaling new highs consistently as they are flooded with RT-PCR tests and other Covid related tests. Maybe this is the best moment ever in their lifetime and it is clearly buying based on pure logic – more Covid, so more tests and thus more business.

Ranbaxy remains in poor health

about 14 years ago

Ranbaxy Labs hit a new 52-week low today at Rs.333.10 and though it has recovered from this low, it remains deeply in the red, down almost 4%. The company has suffered a serious blow post the US FDA findings and though the company has tried to salvage its image by trying to convey through th ...

ANOTHER US FDA WARNING - VICTIMS OR INDEED GUILTY?

about 11 years ago

Today, since morning, Dr.Reddy's Labs has been the top loser with the stock losing 15% in intra day trades. And the same ghost has come back to haunt - US FDA. It's almost like, "Say boooo!" and the entire pharma sector stocks shiver and cover in fright. Dr.Reddy's is one of the best run companies of India. In fact it is one of the finest examples of a thorough bred Indian company, which is an example of a best run company is today under the FDA scanner. When companies like these start getting warning letters, you cannot help but wonder if there is indeed

Pharma and 'Labs' rule today

about 5 years ago

Cipla is the top gainer, up over 7% currently at Rs.964, followed by Dr.Reddy’s, Aurobindo Pharma, Divis Labs, Lupin, Torrent Pharma. Diagnostic stocks – Lalpath Labs, Metropolis, Vijaya Diagnostics,

THE US FDA SCANNER - MORE GET UNDER

about 12 years ago

This is the thought which comes to mind when we read this news today about Ipca labs also being pulled by the 'villain' of Indian pharma companies - the U.S. Food and Drug Administration (U.S. FDA). The stock is the top loser today on news that the FDA has initiated action at the company's Indore SEZ plant and Ratlam API unit.

Dr.Reddy's in good health

about 14 years ago

Dr.Reddy’s Labs is doing very well today morning. The stock is up over 3.5% at Rs.2137 and the stock, on 13th May had hit a new 52-week high at Rs.2150.90. The stock is up in the green after the company posted a good set of numbers for Q4FY13. The company’s PAT at Rs.570 crore, w ...

MSCI Index spurs action

about 5 years ago

Today, action can be seen in stocks, which have been added and deleted from the MSCI Index. Godrej Properties, IRCTC, Mindtree,

Caplin Point down 4.5%

about 2 years ago

The stock slipped 4.5% to hit an intraday low at Rs.1460.25 and is currently trading at Rs.1471 levels. Its 52-week high is at Rs.1617.80.

IPCA hits a new low

about 4 years ago

The stock which had closed yesterday at Rs.825.55, opened lower today at Rs.797.45 and went down to hit a new 52-week low at Rs.751.05.

Dr.Reddy’s up over 2%

about 4 years ago

In the morning trades, the stock rose over 2% to hit an intraday high at Rs.4400 with some 4300 shares changing hands. Its 52-week high and low

Diagnostic stocks get dumped

about 4 years ago

The stock had hit a new 52-week low yesterday at Rs.2151.05 and today once again, it hit another new low at Rs.2019.10.

Tejas Network at 5% UC

about 5 years ago

The stock, which had closed yesterday at Rs.404.70, opened itself at its 5% UC of the day at Rs.424.90, where it now remains frozen. Its 52-week high is at Rs.570.20.

Pharma stocks in focus

about 6 years ago

Thus the second wave has become a reason to celebrate for companies like AstraZeneca, Ipca Labs, Lal Path Labs, Cipla, Dr.Reddy’s , Suven Life Sciences, Divi’s Labs, Thyrocare, Torrent

PI Inds slumps over 8%

about 5 years ago

The stock opened 5% lower at Rs.2850 and went down to an intraday low at Rs.2756.20, plunging over 8%.

Morepen hits new high, again!

about 6 years ago

The stock price soared yesterday to hit a new high at Rs.55.45, closing at Rs.55.20 and today, it once again opened higher at Rs.58.80 and soared to hit another new high at Rs.59.45,

Dr.Reddy’s gets a 'shot'

about 6 years ago

The stock price opened 1.5% higher today morning at Rs.4700 and rose further to Rs.4748, a jump of 2.5% Volumes are pretty robust,

Piramal Entp hits a new high

about 10 years ago

Piramal Enterprises hit a new high today at Rs.1850, up 4% over yesterday’s close of Rs.1780.10. It has come off the high but remains firmly in the green. The stock price is reacting to the company’s announcement that it plans to acquire 100% stake in US based company – Ash ...

Divi's hits all-time high

about 6 years ago

Following this news, Divi's Laboratories hit an all-time high of Rs 3,331 in the early trade, up nearly 4.5%. SBI Life is currently at Rs.880

Cipla brings cheer

about 6 years ago

The stock is in the green; from its close of Rs.634.45, the stock opened at Rs.645.20, which is its intraday high. It is currently come off the high and is trading at Rs.638 levels.

Dr.Reddys rises 7%

about 7 years ago

The stock price reacted positively to this news; it opened 1% higher at Rs.3875 and rose further by 7% to Rs.4099.90.

Aster DM touches 10% UC

about 7 years ago

The stock price has reacted positively to this news, rising 10% in the early trades to touch the 10% UC at Rs.104.50 and it is now quoted at Rs.100 levels

L&T Tech zooms on 'Airbus'

about 7 years ago

L&T Technology Services (LTTS) had closed on Friday at Rs.1487.65 and today, it opened at Rs.1514, which is also the day’s highest point currently.

Sensex @ 60,000 Nifty ~18,000

about 5 years ago

Indian Stock Markets: Still Ripe for Investments

Indoco Remedies in good health

about 11 years ago

Indoco Remedies has shown a jaw-dropping over 42 times surge in volumes and the stock price surging 18% intra day to Rs.314. It remains firmly over Rs.300. Its 52-week high is at Rs.413 and low at Rs.244. The company announced yesterday after market hours that it has received the Establishme ...

FINAL & FIFTH ROUND – NOW THIS IS A UNION BUDGET!

about 7 years ago

Today was the fifth consecutive day of hearing the FM and Anurag Thakur talk and announce measures; all good measures but there is nothing for the short term. And it makes one wonder why was the need to wait for a Covid like crisis to announce all that which the FM did over five days – they all could have come in much earlier.

WISH YOU WERE LISTED......

about 11 years ago

It is human nature - to always aspire for things which are not there, not available. The lure is primarily because it is unavailable. And that is why, despite over 5000 stocks being listed on the BSE, there is always the lure for those stocks, true blue blooded stocks which are unlisted. Maybe on the bourses, amongst listed stocks, we have reached a point where valuations are stretched over the select few stocks and the rest are not

IPO MARKETS - THAT'S WHERE ALL THE ACTION IS!

about 11 years ago

While the secondary market is looking lackluster, hunting around for a trigger, the primary market is seeing some blockbuster action. Take a look at this statistics. In 2014, there were 6 IPOs and they managed to collect Rs.1261 crore. Prior to that, in 2013, there were just 3 IPOs and they garnered Rs.1284 crore.

ENGINEERING COLLEGES SHUTING DOWN – THAT’S A GOOD THING!

about 9 years ago

A couple of years ago, so many youngsters were queuing up to get admission into engineering colleges across India. And today’s news says that BE/BTech seats are going vacant in the engineering colleges across the country - 51% seats were vacant in FY17. Last week’s news was that the All India Council for Technical Education (AICTE) was asking more than 300 private engineering colleges to stop

DECODING THE US FDA JAGONS

about 9 years ago

There was so much hype and hoopla built around the US FDA inspection of Sun Pharma’s Halol plant. This week, it seemed as though the entire pharma sector future hinged on this FDA verdict and today afternoon, the news was finally out. The US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharma’s Halol facility (Gujarat, India) from February 12-23, 2018. At the conclusion of the inspect

THE NAME SAYS IT ALL…..

about 8 years ago

People who change their name are usually eyed with a lot of suspicion as it is assumed that the name change is associated with a lot of hanky- panky activity. And what about companies which do that? One cannot help but wonder why companies would want to change names

MONSOON STOCKS – BEST ‘UMBRELLAS’ FOR THE SEASON!

about 7 years ago

So assuming that we will have a normal monsoon, notwithstanding predictions from weather agencies, these are the sectors which are expected to do well. They are the ones who will reap a rich harvest and you too can, along with them.

THIS IS MACKENNA'S GOLD!

about 6 years ago

So, today we have news of two likely IPOs in the future, both are the crème de la crème when it comes to quality. And that made us think, which are the other such companies which can go public and get investors piqued and improve the depth of the Indian stock markets.

First listing of 2016!

about 11 years ago

Narayana Hrudayala made heartwarming debut on the bourses today. The stock got listed on the NSE at Rs.299, a good 20% higher than the issue price of Rs.250/share. It went on to hit an intra day high of Rs.316. The stock had got subscribed 8.67 times, raising Rs.184 crore fr ...

HIGHLY IMPACTFUL, EXPANSIONARY BUDGET

about 6 years ago

Its good economics that the FM decided to go all-out and loosen all purse strings, irrespective of the fiscal deficit. The Budget clearly shows that the aim is to revive the economy and expenditure can be worried about later. An increased spend in healthcare, railways, highways, ports, airports – all this bodes well.

NFTs - PROOF THAT WORLD IS GETTING MADDER!

about 5 years ago

Having dabbled in stocks, especially IPOs; having bought innumerable realty projects; FDs and bonds are even beyond count; gold and diamond is like passe; so when people like these have more surplus money to invest, where do the well-heeled High Networth Individuals (HNIs) put the money?

Celestial Bio

about 20 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Dr Lal PathLabs

about 11 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Healthcare in green, markets in red

about 12 years ago

While the broader markets are in the red, both NSE and BSE down 1% each, some healthcare stocks are going against the flow, and are firmly in the green since morning. While Astrazeneca Pharma may be locked in upper circuit due to announcement of new launch, other biggies in the pharma pack are sh ...

Pharma stocks in focus

about 6 years ago

The top five gainers and more are all pharma stocks – Suven, Novartis, AstraZeneca, Morepen Labs, Shilpa Med, Panacea Bio, Wockhardt, Vivimed Labs, Marksans, Alembic, Cipla, Sun Pharma

Trump's tariff hurts textiles

about 1 year ago

Trump's 50% tariff on Indian exports to USA take effect and here we have a quick look at the sectors and stocks that will be likely impacted.